The histamine H3 receptor:: gene organization, multiple isoforms, constitutive activity and molecular pharmacology

被引:0
|
作者
Arrang, JM [1 ]
Morisset, S [1 ]
Rouleau, A [1 ]
Tardivel-Lacombe, J [1 ]
Gbahou, F [1 ]
Ligneaux, X [1 ]
Héron, A [1 ]
Sasse, A [1 ]
Stark, H [1 ]
Shunack, W [1 ]
Ganellin, CR [1 ]
Schwartz, JC [1 ]
机构
[1] INSERM, Unite Neurobiol & Pharmacol Mol, U109, Ctr Paul Broca, F-75014 Paris, France
来源
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
We show by genomic DNA analysis that the coding region of the rat H-3 receptor comprises three exons interrupted by two introns located in the second transmembrane domain and second intracellular loop, respectively. We have identified several isoforms of the receptor by cDNA cloning. Four variants, termed H-3(445), H-3(410), H-3(410) and H-3(397) and generated by pseudo-intron retention/deletion at the level of the third intracellular loop, display rather similar pharmacological profiles but differential tissue expression. Two short variants, termed H-3(nf1) and H-3(nf2) and corresponding to frame shift and stop codon interposition, are presumably non functional. We have assigned the human H-3 receptor gene to the telomeric region of the q arm of chromosome 20 and shown that the organization of the coding region of the human and rat H-3 receptor genes is similar. Whereas the two deduced proteins differ by only five amino acids at the level of the transmembrane domains. we show that some ligands display distinct affinities for the recombinant rat and human H-3 receptors, a difference that we assign to two aminoacids in TM3. Finally, we show that the recombinant H-3 receptor displays high constitutive activity and, having identified a neutral antagonist, we use it to demonstrate that native H-3 autoreceptors also display high constitutive activity in their control of histaminergic neuron activity in vitro and in vivo.
引用
收藏
页码:9 / 21
页数:13
相关论文
共 50 条
  • [21] Differences in pharmacological properties of histamine H3 receptor agonists and antagonists revealed at two human H3 receptor isoforms
    T. A. Esbenshade
    K. M. Krueger
    B. B. Yao
    D. G. Witte
    B. R. Estvander
    J. L. Baranowski
    T. R. Miller
    A. A. Hancock
    Inflammation Research, 2006, 55 : S45 - S46
  • [22] Differences in pharmacological properties of histamine H3 receptor agonists and antagonists revealed at two human H3 receptor isoforms
    Esbenshade, TA
    Krueger, KM
    Yao, BB
    Witte, DG
    Estvander, BR
    Baranowski, JL
    Miller, TR
    Hancock, AA
    INFLAMMATION RESEARCH, 2006, 55 (Suppl 1) : S45 - S46
  • [23] Differential CNS expression and functional activity of multiple human H3 receptor isoforms
    T. A. Esbenshade
    M. I. Strakhova
    T. L. Carr
    R. Sharma
    D. G. Witte
    B. B. Yao
    T. R. Miller
    A. A. Hancock
    Inflammation Research, 2006, 55 : S38 - S39
  • [24] Differential CNS expression and functional activity of multiple human H3 receptor isoforms
    Esbenshade, TA
    Strakhova, MI
    Carr, TL
    Sharma, R
    Witte, DG
    Yao, BB
    Miller, TR
    Hancock, AA
    INFLAMMATION RESEARCH, 2006, 55 (Suppl 1) : S38 - S39
  • [25] Multiple Targeting Approaches on Histamine H3 Receptor Antagonists
    Khanfar, Mohammad A.
    Affini, Anna
    Lutsenko, Kiril
    Nikolic, Katarina
    Butini, Stefania
    Stark, Holger
    FRONTIERS IN NEUROSCIENCE, 2016, 10
  • [26] Constitutive activity of the recombinant and native histamine H3 receptor:: effects of inverse agonists and protean agonists
    Gbahou, F
    Rouleau, A
    Morisset, S
    Ligneau, X
    Tardivel-Lacombe, J
    Parmentier, R
    Crochet, S
    Lin, JS
    Stark, H
    Schunack, W
    Ganellin, CR
    Schwartz, JC
    Arrang, JM
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S4 - S5
  • [27] Molecular and pharmacological characterization of the monkey histamine H3 receptor
    Yao, BB
    Sharma, R
    Cassar, S
    Faghih, R
    Bermani, Y
    Esbenshade, TA
    Hancock, AA
    INFLAMMATION RESEARCH, 2004, 53 (Suppl 1) : S75 - S76
  • [28] Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971
    Hey, JA
    Aslanian, R
    Bolser, DC
    Chapman, RW
    Egan, RW
    Rizzo, CA
    Shih, NY
    Fernandez, X
    McLeod, RL
    West, R
    Kreutner, W
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 1998, 48 (09): : 881 - 888
  • [29] Molecular and pharmacological characterization of the monkey histamine H3 receptor
    B. B. Yao
    R. Sharma
    S. Cassar
    R. Faghih
    Y. Bennani
    T. A. Esbenshade
    A. A. Hancock
    Inflammation Research, 2004, 53 : S75 - S76
  • [30] Recent advances in molecular pharmacology of the histamine systems:: Physiology and pharmacology of histamine H3 receptor:: Roles in feeding regulation and therapeutic potential for metabolic disorders
    Tokita, Shigeru
    Takahashi, Kazuhiko
    Kotani, Hidehito
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 101 (01) : 12 - 18